Physician profile
Dwayne Ledesma
NPI 1013995687
$13,402.41
in general payments reported to CMS, 2019-2025
10 companies · $140 in 2025
The $140 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,677 · 2020: $1,443 · 2021: $341 · 2022: $422 · 2023: $3,715 · 2024: $664 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,165 · Food and Beverage: $1,159 · Travel and Lodging: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,165.00 |
| Food and Beverage | $1,158.69 |
| Travel and Lodging | $195.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,517.30 | 2019-2024 | |
| Angiodynamics, INC. | $229.56 | 2023 | Venacure 1470 Pro, Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $223.30 | 2023-2025 | Endurant Iis, Heli-Fx Endoanchor System |
| Cardiovascular Systems INC. | $191.61 | 2019-2022 | |
| Conmed Corporation | $85.50 | 2023-2025 | Airseal, Visiclear |
| Davol INC. | $61.81 | 2023 | Phasix Mesh |
| Silk Road Medical, INC. | $34.11 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Abbott Laboratories | $27.04 | 2025 | Absolute Pro |
| Boston Scientific Corporation | $18.57 | 2025 | Jetstream Sc |
| Medtronic Vascular, INC. | $13.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwayne Ledesma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.